Immune System Components
Innate Immunity (Non-specific)
The innate immune system provides the first line of defense and responds rapidly (minutes to hours) to pathogens without prior sensitization.
| Component |
Function |
Key Markers/Features |
| Physical barriers |
Skin, mucous membranes, epithelial tight junctions |
Desquamation, antimicrobial peptides |
| Phagocytes |
Macrophages, neutrophils, dendritic cells |
NK cells: CD16+, CD56+; Macrophages: CD14+, CD68+ |
| Complement system |
Opsonization, lysis, inflammation |
C3a, C5a, membrane attack complex |
| Dendritic cells |
Antigen presentation, bridge to adaptive |
CD11c+, HLA-DR+, CD141+ (cDC1), CD1c+ (cDC2) |
| Natural killer cells |
cytotoxic killing of infected/tumor cells |
CD16+, CD56dim/bright |
| Pattern recognition receptors |
TLRs, NLRs, RLRs |
TLR4 (LPS), TLR3 (viral dsRNA) |
Adaptive Immunity (Antigen-specific)
The adaptive immune system develops over days and provides long-lasting protection through immunological memory.
| Component |
Function |
Key Markers |
| B cells |
Antibody production, antigen presentation |
CD19+, CD20+, CD21+, surface Ig+ |
| T helper cells (CD4+) |
Helper functions, cytokine production |
CD3+, CD4+ |
| T cytotoxic cells (CD8+) |
Direct killing of infected cells |
CD3+, CD8+ |
| Regulatory T cells |
Immune tolerance |
CD4+, CD25+, FOXP3+ |
| Memory B cells |
Long-term antibody production |
CD27+, IgD- |
| Memory T cells |
Rapid secondary response |
CD45RO+, CD27+ |
Antibody Biology
Antibody Structure
Immunoglobulins (Ig) are Y-shaped proteins composed of two heavy chains and two light chains.
┌──────────────────────────────────────┐
│ Variable Region │
│ (VH - Heavy Chain) │
│ (VL - Light Chain) │
└──────────────────┬───────────────────┘
╱ ╲
┌────────────────┴───┴────────────────┐
│ Hinge Region │
└──────────────────┬───────────────────┘
┌──────────────────┴───────────────────┐
│ Constant Region (CH) │
└──────────────────────────────────────┘
┌──────────────┐
│ Light │
│ Chain │
│ (CL) │
└──────────────┘
Antibody Classes (Isotypes)
| Isotype |
Structure |
Primary Location |
Key Functions |
| IgG |
Monomer (γ heavy chain) |
Blood, extracellular fluid |
Secondary response, opsonization, complement activation, placental transfer |
| IgA |
Dimer (α heavy chain) |
Mucous membranes, secretions |
Mucosal immunity, dimeric with secretory component |
| IgM |
Pentamer (μ heavy chain) |
Blood, B cell surface |
Primary response, complement activation, B cell receptor |
| IgE |
Monomer (ε heavy chain) |
Basophils, mast cells |
Allergy, parasite defense, bound to FcεRI |
| IgD |
Monomer (δ heavy chain) |
B cell surface, blood |
Coadministration with IgM, B cell activation |
Antibody Naming Conventions
- Polyclonal antibodies: Multiple epitopes, heterogeneous preparation
- Monoclonal antibodies: Single epitope, homogeneous, produced by hybridomas
- Nomenclature: Prefix + target + -mab (e.g., pembrolizumab, rituximab)
- Humanized antibodies: Murine variable regions grafted to human framework
T-Cell Immunology
T-Cell Receptor (TCR) Biology
The TCR is a heterodimer (αβ or γδ) that recognizes antigens presented on MHC molecules.
TCR Complex:
┌─────────────────────────────────────────┐
│ αβ Heterodimer (TCR) │
├─────────────────────────────────────────┤
│ CD3 Complex (Signal Transduction)│
│ ζ-chain (homodimer) │
├─────────────────────────────────────────┤
│ CD4 or CD8 Coreceptor │
└─────────────────────────────────────────┘
Major Histocompatibility Complex (MHC)
| MHC Class |
Presents To |
Cell Types |
Gene Location |
| MHC Class I |
CD8+ T cells |
All nucleated cells |
HLA-A, -B, -C |
| MHC Class II |
CD4+ T cells |
Professional APCs (DC, macrophages, B cells) |
HLA-DP, -DQ, -DR |
T-Cell Differentiation States
| Subset |
Master Transcription Factor |
Cytokines Produced |
Function |
| Th1 |
T-bet |
IFN-γ, IL-2 |
Cellular immunity, viral defense |
| Th2 |
GATA3 |
IL-4, IL-5, IL-13 |
Humoral immunity, allergy |
| Th17 |
RORγt |
IL-17, IL-22 |
Mucosal defense, autoimmunity |
| Tfh |
BCL6 |
IL-21 |
B cell help in germinal centers |
| Treg |
FOXP3 |
IL-10, TGF-β |
Immune tolerance |
Cytokines & Immune Signaling
Key Cytokines
| Cytokine |
Source |
Primary Target |
Function |
| IL-1β |
Macrophages, DCs |
Wide range |
Inflammation, fever, leukocyte recruitment |
| IL-6 |
Macrophages, T cells |
Liver, immune cells |
Acute phase response, B cell differentiation |
| IFN-α/β |
Various cells |
Various cells |
Antiviral state, MHC I upregulation |
| IFN-γ |
Th1, NK cells |
Macrophages, various cells |
Macrophage activation, Th1 differentiation |
| TNF-α |
Macrophages, T cells |
Wide range |
Inflammation, apoptosis, cachexia |
| IL-10 |
Treg, Th2, macrophages |
Wide range |
Anti-inflammatory, inhibits APCs |
| IL-12 |
DCs, macrophages |
NK, Th1 |
Th1 differentiation, NK activation |
| IL-17A/F |
Th17 |
Epithelial cells, fibroblasts |
Pro-inflammatory, neutrophil recruitment |
Signaling Pathways
# Cytokine signaling conceptual model
class CytokineSignaling:
"""Simplified cytokine signaling pathway model"""
JAK_STAT_PATHWAY = {
"Type I (e.g., IL-6)": {
"receptor": "gp130 family",
"JAKs": "JAK1, JAK2, TYK2",
"STATs": "STAT1, STAT3",
"outcome": "Acute phase response, B cell differentiation"
},
"Type II (e.g., IFN-γ)": {
"receptor": "IFNAR family",
"JAKs": "JAK1, JAK2",
"STATs": "STAT1, STAT2",
"outcome": "MHC upregulation, antiviral response"
}
}
NFκB_PATHWAY = {
"canonical": {
"activators": ["TNF-α", "IL-1β", "LPS", "TLRs"],
"IKK_complex": "IKKα, IKKβ, IKKγ",
"inhibitor": "IκBα",
"transcription_factor": "p65/p50"
}
}
Flow Cytometry Analysis
Sample Preparation
- Cell count and viability: Aim for >90% viability, 1×10⁶ cells/mL
- Staining: Surface markers (4°C, 30 min) → intracellular (fix/perm)
- Controls:
- Unstained control (autofluorescence)
- Fluorescence minus one (FMO)
- Isotype controls
- Viability dye
Common Fluorophores
| Fluorophore |
Excitation (nm) |
Emission (nm) |
Channels |
| FITC |
488 |
519 |
Green |
| PE |
488 |
578 |
Yellow-orange |
| APC |
633 |
660 |
Red |
| PerCP-Cy5.5 |
488 |
710 |
Deep red |
| Pacific Blue |
405 |
450 |
Blue |
| BV421 |
405 |
421 |
Blue |
Gating Strategy Example
Raw Data
↓ (FS/SS gate) → Lymphocyte gate
↓ (Single cells) → Live/Dead exclusion
↓ (CD45+) → Leukocyte population
↓ (CD3+) → T cells
↓ (CD4/CD8) → Helper vs Cytotoxic
↓ (CD45RA/CCR7) → Naive vs Memory
Autoimmunity & Immunodeficiency
Autoimmune Disease Classification
| Category |
Examples |
Autoantibodies |
Mechanism |
| Systemic |
SLE, RA, Sjögren |
Anti-dsDNA, RF |
Anti-nuclear antibodies |
| Organ-specific |
Type 1 Diabetes, Graves' |
Anti-insulin, Anti-TSHR |
Tissue-specific autoimmunity |
| Cell-mediated |
Multiple sclerosis |
T cells reactive to myelin |
Delayed-type hypersensitivity |
Primary Immunodeficiencies
| Disorder |
Defect |
Clinical Features |
Treatment |
| SCID |
Adaptive immunity absent |
Severe infections, failure to thrive |
BMT, gene therapy |
| X-linked agammaglobulinemia |
B cell development |
Bacterial infections |
IVIG |
| Chronic granulomatous disease |
NADPH oxidase |
Recurrent catalase+ infections |
IFN-γ, prophylaxis |
| Hyper-IgM syndrome |
Class-switching defect |
Opportunistic infections |
IVIG, prophylaxis |
Vaccine Immunology
Vaccine Types
| Type |
Example |
Mechanism |
| Live attenuated |
MMR, Varicella |
Replication-competent, mimics natural infection |
| Inactivated |
Polio (IPV), Rabies |
Killed pathogen, cannot replicate |
| Subunit |
Hepatitis B, HPV |
Protein/polysaccharide antigens only |
| Toxoid |
Tetanus, Diphtheria |
Inactivated toxins |
| mRNA |
COVID-19 mRNA vaccines |
In vivo protein production |
| Viral vector |
Ebola, some COVID-19 |
Recombinant viral expression |
Vaccine Response Evaluation
# Serological response interpretation
class VaccineResponse:
"""Interpret vaccine-induced immune responses"""
def calculate_seroconversion(self, pre_titer, post_titer, threshold=4):
"""4-fold rise = seroconversion"""
if pre_titer < threshold:
return post_titer >= threshold
return post_titer / pre_titer >= 4
def interpret_protective_titer(self, antibody_level, protective_level=10):
"""Assess if titer exceeds protective threshold"""
return antibody_level >= protective_level
# Memory B cell response (flow cytometry)
def memory_bcell_response(self, antigen_specific_bcells, total_bcells):
"""Calculate percentage of antigen-specific memory B cells"""
if total_bcells == 0:
return 0
return (antigen_specific_bcells / total_bcells) * 100
Immunological Techniques
ELISA (Enzyme-Linked Immunosorbent Assay)
| Type |
Detection |
Use Cases |
| Direct ELISA |
Antigen detection |
Infection diagnosis |
| Indirect ELISA |
Antibody detection |
Vaccine response |
| Sandwich ELISA |
Antigen detection in complexes |
Disease biomarkers |
| Competitive ELISA |
Low molecular weight analytes |
Hormones, drugs |
Western Blot
- Purpose: Detect specific proteins in a mixture
- Detection: Primary antibody + enzyme-conjugated secondary antibody
- Substrate: Chemiluminescent (ECL), colorimetric, fluorescent
Common Errors to Avoid
- Ignoring Fc receptor binding — use Fc block for phagocyte staining
- Not accounting for dead cells — always include viability dye
- Insufficient controls — FMO is essential for proper gating
- Citing antibody clone without validation — verify specificity
- Assuming isotype controls match primary — they should match fluorophore
- Over-gating rare populations — report parent population percentages
- Confusing correlation with causation — functional assays validate phenotypic findings
1---2name: immunology3description: Immune System Components4---56## Immune System Components78### Innate Immunity (Non-specific)910The innate immune system provides the first line of defense and responds rapidly (minutes to hours) to pathogens without prior sensitization.1112|Component|Function|Key Markers/Features|13|---------|--------|-------------------|14|**Physical barriers**|Skin, mucous membranes, epithelial tight junctions|Desquamation, antimicrobial peptides|15|**Phagocytes**|Macrophages, neutrophils, dendritic cells|NK cells: CD16+, CD56+; Macrophages: CD14+, CD68+|16|**Complement system**|Opsonization, lysis, inflammation|C3a, C5a, membrane attack complex|17|**Dendritic cells**|Antigen presentation, bridge to adaptive|CD11c+, HLA-DR+, CD141+ (cDC1), CD1c+ (cDC2)|18|**Natural killer cells**| cytotoxic killing of infected/tumor cells|CD16+, CD56dim/bright|19|**Pattern recognition receptors**|TLRs, NLRs, RLRs|TLR4 (LPS), TLR3 (viral dsRNA)|2021### Adaptive Immunity (Antigen-specific)2223The adaptive immune system develops over days and provides long-lasting protection through immunological memory.2425|Component|Function|Key Markers|26|---------|--------|------------|27|**B cells**|Antibody production, antigen presentation|CD19+, CD20+, CD21+, surface Ig+|28|**T helper cells (CD4+)**|Helper functions, cytokine production|CD3+, CD4+|29|**T cytotoxic cells (CD8+)**|Direct killing of infected cells|CD3+, CD8+|30|**Regulatory T cells**|Immune tolerance|CD4+, CD25+, FOXP3+|31|**Memory B cells**|Long-term antibody production|CD27+, IgD-|32|**Memory T cells**|Rapid secondary response|CD45RO+, CD27+|3334---3536## Antibody Biology3738### Antibody Structure3940Immunoglobulins (Ig) are Y-shaped proteins composed of two heavy chains and two light chains.4142```43 ┌──────────────────────────────────────┐44 │ Variable Region │45 │ (VH - Heavy Chain) │46 │ (VL - Light Chain) │47 └──────────────────┬───────────────────┘48 ╱ ╲49 ┌────────────────┴───┴────────────────┐50 │ Hinge Region │51 └──────────────────┬───────────────────┘52 ┌──────────────────┴───────────────────┐53 │ Constant Region (CH) │54 └──────────────────────────────────────┘55 ┌──────────────┐56 │ Light │57 │ Chain │58 │ (CL) │59 └──────────────┘60```6162### Antibody Classes (Isotypes)6364|Isotype|Structure|Primary Location|Key Functions|65|-------|---------|-----------------|---------------|66|**IgG**|Monomer (γ heavy chain)|Blood, extracellular fluid|Secondary response, opsonization, complement activation, placental transfer|67|**IgA**|Dimer (α heavy chain)|Mucous membranes, secretions|Mucosal immunity, dimeric with secretory component|68|**IgM**|Pentamer (μ heavy chain)|Blood, B cell surface|Primary response, complement activation, B cell receptor|69|**IgE**|Monomer (ε heavy chain)|Basophils, mast cells|Allergy, parasite defense, bound to FcεRI|70|**IgD**|Monomer (δ heavy chain)|B cell surface, blood|Coadministration with IgM, B cell activation|7172### Antibody Naming Conventions7374- **Polyclonal antibodies**: Multiple epitopes, heterogeneous preparation75- **Monoclonal antibodies**: Single epitope, homogeneous, produced by hybridomas76- **Nomenclature**: Prefix + target + -mab (e.g., pembrolizumab, rituximab)77- **Humanized antibodies**: Murine variable regions grafted to human framework7879---8081## T-Cell Immunology8283### T-Cell Receptor (TCR) Biology8485The TCR is a heterodimer (αβ or γδ) that recognizes antigens presented on MHC molecules.8687```88TCR Complex:89┌─────────────────────────────────────────┐90│ αβ Heterodimer (TCR) │91├─────────────────────────────────────────┤92│ CD3 Complex (Signal Transduction)│93│ ζ-chain (homodimer) │94├─────────────────────────────────────────┤95│ CD4 or CD8 Coreceptor │96└─────────────────────────────────────────┘97```9899### Major Histocompatibility Complex (MHC)100101|MHC Class|Presents To|Cell Types| Gene Location|102|---------|-----------|----------|--------------|103|**MHC Class I**|CD8+ T cells|All nucleated cells|HLA-A, -B, -C|104|**MHC Class II**|CD4+ T cells|Professional APCs (DC, macrophages, B cells)|HLA-DP, -DQ, -DR|105106### T-Cell Differentiation States107108|Subset|Master Transcription Factor|Cytokines Produced|Function|109|------|---------------------------|------------------|--------|110|**Th1**|T-bet|IFN-γ, IL-2|Cellular immunity, viral defense|111|**Th2**|GATA3|IL-4, IL-5, IL-13|Humoral immunity, allergy|112|**Th17**|RORγt|IL-17, IL-22|Mucosal defense, autoimmunity|113|**Tfh**|BCL6|IL-21|B cell help in germinal centers|114|**Treg**|FOXP3|IL-10, TGF-β|Immune tolerance|115116---117118## Cytokines & Immune Signaling119120### Key Cytokines121122|Cytokine|Source|Primary Target|Function|123|--------|------|---------------|--------|124|**IL-1β**|Macrophages, DCs|Wide range|Inflammation, fever, leukocyte recruitment|125|**IL-6**|Macrophages, T cells|Liver, immune cells|Acute phase response, B cell differentiation|126|**IFN-α/β**|Various cells|Various cells|Antiviral state, MHC I upregulation|127|**IFN-γ**|Th1, NK cells|Macrophages, various cells|Macrophage activation, Th1 differentiation|128|**TNF-α**|Macrophages, T cells|Wide range|Inflammation, apoptosis, cachexia|129|**IL-10**|Treg, Th2, macrophages|Wide range|Anti-inflammatory, inhibits APCs|130|**IL-12**|DCs, macrophages|NK, Th1|Th1 differentiation, NK activation|131|**IL-17A/F**|Th17|Epithelial cells, fibroblasts|Pro-inflammatory, neutrophil recruitment|132133### Signaling Pathways134135```python136# Cytokine signaling conceptual model137class CytokineSignaling:138 """Simplified cytokine signaling pathway model"""139 140 JAK_STAT_PATHWAY = {141 "Type I (e.g., IL-6)": {142 "receptor": "gp130 family",143 "JAKs": "JAK1, JAK2, TYK2",144 "STATs": "STAT1, STAT3",145 "outcome": "Acute phase response, B cell differentiation"146 },147 "Type II (e.g., IFN-γ)": {148 "receptor": "IFNAR family", 149 "JAKs": "JAK1, JAK2",150 "STATs": "STAT1, STAT2",151 "outcome": "MHC upregulation, antiviral response"152 }153 }154 155 NFκB_PATHWAY = {156 "canonical": {157 "activators": ["TNF-α", "IL-1β", "LPS", "TLRs"],158 "IKK_complex": "IKKα, IKKβ, IKKγ",159 "inhibitor": "IκBα",160 "transcription_factor": "p65/p50"161 }162 }163```164165---166167## Flow Cytometry Analysis168169### Sample Preparation1701711. **Cell count and viability**: Aim for >90% viability, 1×10⁶ cells/mL1722. **Staining**: Surface markers (4°C, 30 min) → intracellular (fix/perm)1733. **Controls**:174 - Unstained control (autofluorescence)175 - Fluorescence minus one (FMO)176 - Isotype controls177 - Viability dye178179### Common Fluorophores180181|Fluorophore|Excitation (nm)|Emission (nm)|Channels|182|-----------|---------------|--------------|--------|183|FITC|488|519|Green|184|PE|488|578|Yellow-orange|185|APC|633|660|Red|186|PerCP-Cy5.5|488|710|Deep red|187|Pacific Blue|405|450|Blue|188|BV421|405|421|Blue|189190### Gating Strategy Example191192```193Raw Data194 ↓ (FS/SS gate) → Lymphocyte gate195 ↓ (Single cells) → Live/Dead exclusion196 ↓ (CD45+) → Leukocyte population197 ↓ (CD3+) → T cells198 ↓ (CD4/CD8) → Helper vs Cytotoxic199 ↓ (CD45RA/CCR7) → Naive vs Memory200```201202---203204## Autoimmunity & Immunodeficiency205206### Autoimmune Disease Classification207208|Category|Examples|Autoantibodies|Mechanism|209|--------|--------|---------------|----------|210|**Systemic**|SLE, RA, Sjögren|Anti-dsDNA, RF|Anti-nuclear antibodies|211|**Organ-specific**|Type 1 Diabetes, Graves'|Anti-insulin, Anti-TSHR|Tissue-specific autoimmunity|212|**Cell-mediated**|Multiple sclerosis|T cells reactive to myelin|Delayed-type hypersensitivity|213214### Primary Immunodeficiencies215216|Disorder|Defect|Clinical Features|Treatment|217|---------|------|------------------|----------|218|**SCID**|Adaptive immunity absent|Severe infections, failure to thrive|BMT, gene therapy|219|**X-linked agammaglobulinemia**|B cell development|Bacterial infections|IVIG|220|**Chronic granulomatous disease**|NADPH oxidase|Recurrent catalase+ infections|IFN-γ, prophylaxis|221|**Hyper-IgM syndrome**|Class-switching defect|Opportunistic infections|IVIG, prophylaxis|222223---224225## Vaccine Immunology226227### Vaccine Types228229|Type|Example|Mechanism|230|----|-------|----------|231|**Live attenuated**|MMR, Varicella|Replication-competent, mimics natural infection|232|**Inactivated**|Polio (IPV), Rabies|Killed pathogen, cannot replicate|233|**Subunit**|Hepatitis B, HPV|Protein/polysaccharide antigens only|234|**Toxoid**|Tetanus, Diphtheria|Inactivated toxins|235|**mRNA**|COVID-19 mRNA vaccines|In vivo protein production|236|**Viral vector**|Ebola, some COVID-19|Recombinant viral expression|237238### Vaccine Response Evaluation239240```python241# Serological response interpretation242class VaccineResponse:243 """Interpret vaccine-induced immune responses"""244 245 def calculate_seroconversion(self, pre_titer, post_titer, threshold=4):246 """4-fold rise = seroconversion"""247 if pre_titer < threshold:248 return post_titer >= threshold249 return post_titer / pre_titer >= 4250 251 def interpret_protective_titer(self, antibody_level, protective_level=10):252 """Assess if titer exceeds protective threshold"""253 return antibody_level >= protective_level254 255 # Memory B cell response (flow cytometry)256 def memory_bcell_response(self, antigen_specific_bcells, total_bcells):257 """Calculate percentage of antigen-specific memory B cells"""258 if total_bcells == 0:259 return 0260 return (antigen_specific_bcells / total_bcells) * 100261```262263---264265## Immunological Techniques266267### ELISA (Enzyme-Linked Immunosorbent Assay)268269|Type|Detection|Use Cases|270|----|---------|----------|271|Direct ELISA|Antigen detection|Infection diagnosis|272|Indirect ELISA|Antibody detection|Vaccine response|273|Sandwich ELISA|Antigen detection in complexes|Disease biomarkers|274|Competitive ELISA|Low molecular weight analytes|Hormones, drugs|275276### Western Blot277278- **Purpose**: Detect specific proteins in a mixture279- **Detection**: Primary antibody + enzyme-conjugated secondary antibody280- **Substrate**: Chemiluminescent (ECL), colorimetric, fluorescent281282### Common Errors to Avoid2832841. **Ignoring Fc receptor binding** — use Fc block for phagocyte staining2852. **Not accounting for dead cells** — always include viability dye2863. **Insufficient controls** — FMO is essential for proper gating2874. **Citing antibody clone without validation** — verify specificity2885. **Assuming isotype controls match primary** — they should match fluorophore2896. **Over-gating rare populations** — report parent population percentages2907. **Confusing correlation with causation** — functional assays validate phenotypic findings291